Biological Character of Immortalized Rat Astrocyte Strain by Transferction of Simian Large T Antigen Gents

安珂,田玉科,杨辉,高峰,王鹏
DOI: https://doi.org/10.3760/j.issn:0254-1416.2005.06.010
2005-01-01
Abstract:Objective To study the biological character of rat astrocyte strain immortalized by simian virus 40 large T antigen gene(SV40Tag) and explore the feasibility of using it as cell vehicle for transgenic cellular analgesia.Methods Rat cerebral cortical astrocytes (AST) and immortalized rat astrocyte strain (IAST) were cultured in vitro. Morphology and growth features of AST and IAST were examined and compared after subculture, freezing and recovery. The ultrastructure of the cells was observed by transmission electron microscopy. The glial fibrillary acidic protein (GFAP) in these cells was detected by immuno-cytochemistry. The cell proliferation rate and cell cycle were determined by bromodeoxyuridine labelling and flow cytometry. AST and IAST were cultured in soft agar and inoculated in nude mice to investigate the tumorigenesis of IAST. Results LAST could be subcultured successively. The cells remained monolayer, anchorage dependent and the growth was attachment-inhibited. When AST was subcultured for only 10 passages, replicative senescense began. Subculture, freezing and recovery did not influence the shape and proliferation of IAST (94%±5%) , but decreased the vitality rate of AST (54%±4% ) (P0.01) . The proliferation capability of IAST was stronger than that of AST. The proliferation index was increased (9.6%±2.6% vs 30.7%±3.4%) (P0.01); population doubling time was shortened [(50.0±3.2)h vs (19.6±2.1)h](P 0.01) and proliferation rate was increased (21%±3% vs 72%±7%) (P 0.01). Moreover IAST was positively immunostained for GFAP and retained its original differentiation phenotype. IAST did not form clone in soft agar and no tumor was developed in nude mice. Conclusion IAST immortalized by SV40Tag proliferates vigorously in vitro and does not belong to malignant transformed cells, so IAST could be used safely in transgenic cellular analgesia.
What problem does this paper attempt to address?